Bionano Genomics, Inc. (BNGO) Earnings Call Transcript & Summary

September 29, 2020

NASDAQ US Health Care Life Sciences Tools and Services shareholder_meeting 3 min

Earnings Call Speaker Segments

Operator

operator
#1

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Bionano Genomics' Conference Call. At this time, I would like to turn the conference over to Mr. Erik Holmlin.

Robert Holmlin

executive
#2

Thank you, and good morning, everyone. I am Erik Holmlin, President and Chief Executive Officer of Bionano Genomics. And I will serve today as the Chair, Secretary and inspector of election of today's meeting. And so welcome again to the Bionano's Special Meeting of Stockholders. As you know, this meeting was originally convened at 10:00 a.m. Pacific Time on August 31, 2020. At that time, we announced the adjournment of the meeting until today to allow Bionano additional time to solicit proxies for Proposal 1 relating to an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock from 200 million to 400 million shares. At this time, the meeting will now officially come to order. The time is now 10:01 a.m. on September 29, 2020, and the polls are open for voting on Proposal 1 as set forth in the proxy statement for the special meeting. [Voting]

Robert Holmlin

executive
#3

The time is now 10:02 a.m., and the polls are now closed for voting on Proposal 1. In my capacity as the inspector of election, I hereby report as follows: Proposal 1, to approve an amendment to Bionano's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200 million to 400 million shares is carried. We expect to report our preliminary voting results, or if available to us on a timely basis, our final voting results on an amendment to our current report on Form 8-K to be filed with the SEC within 4 business days from now. If not reported earlier, we expect to report our final voting results in amendment to our Form 8-K within 4 business days after the final results are known to us. This concludes our special meeting of stockholders. Thank you for your attendance today and for your continued support of Bionano.

For developers and AI pipelines

Programmatic access to Bionano Genomics, Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.